Trade DERM stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Journey Medical Corporation (DERM) is trading at US$7.45, down 6.52% today as of Sep 9, 16:00 EDT. The company has a market capitalisation of US$218.74M. Over the past 52 weeks, DERM has traded between US$4.31 and US$9.56. On Syfe you can trade DERM with $0 commission and add it to your watchlist.
| Previous close | US$7.97 |
|---|---|
| Market cap | US$218.74M |
| P/E ratio | 16.30 |
| 52-week range | US$4.31 – US$9.56 |
| Volume | 117.9K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Journey Medical Corporation
Journey Medical Corporation is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.
Year: 2021
Journey Medical Secures Third Major Contract Expanding Access to Emrosi
Apr 21, 2:51 PM · MT Newswires
Journey Medical 2025 Net Loss Narrows; Revenue Rises
Mar 25, 8:38 PM · MT Newswires
Journey Medical Corporation (DERM) stock is trading at US$7.45, -6.52% from the previous close of US$7.97.
The market cap for Journey Medical Corporation (DERM) stock is approximately US$218.74M.
The price-to-earnings ratio for Journey Medical Corporation (DERM) is 16.30, based on the latest reported earnings.
The 52-week high for Journey Medical Corporation (DERM) stock is US$9.56.
The 52-week low for Journey Medical Corporation (DERM) stock is US$4.31.
Journey Medical Corporation (DERM) does not currently pay a dividend.
Stay on top of DERM
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
